Low-density lipoprotein, non-high-density lipoprotein, and apolipoprotein B as targets of lipid-lowering therapy.
Feeman
W E
WE
D001055:Apolipoproteins B / Q000097:blood*; D001161:Arteriosclerosis / Q000097:blood / Q000453:epidemiology / Q000517:prevention & control*; D001794:Blood Pressure; D008078:Cholesterol, LDL / Q000097:blood; D003661:Decision Support Techniques; D006801:Humans; D000960:Hypolipidemic Agents / Q000494:pharmacology*; D008074:Lipoproteins / Q000097:blood*; D008077:Lipoproteins, LDL / Q000097:blood; D009820:Ohio / Q000453:epidemiology; D018570:Risk Assessment; D012307:Risk Factors; D013927:Thrombosis / Q000097:blood / Q000453:epidemiology / Q000517:prevention & control*
D001055:Apolipoproteins B; D008078:Cholesterol, LDL; D000960:Hypolipidemic Agents; D008074:Lipoproteins; D008077:Lipoproteins, LDL